The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria
Open accessAbstract
Phage therapy, long overshadowed by chemical antibiotics, is garnering renewed interest in Western medicine. This stems from the rise in frequency of multi-drug-resistant bacterial infections in humans. There also have been recent case reports of phage therapy demonstrating clinical utility in resolving these otherwise intractable infections. Nevertheless, bacteria can readily evolve phage resistance too, making it crucial for modern phage therapy to develop strategies to capitalize on this inevitability. Here, we review the history of phage therapy research. We compare and contrast phage therapy and chemical antibiotics, highlighting their potential synergies when used in combination. We also examine the use of animal models, case studies, and results from clinical trials. Throughout, we explore how the modern scientific community works to improve the reliability and success of phage therapy in the clinic and discuss how to properly evaluate the potential for phage therapy to combat antibiotic-resistant bacteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kaper, J. B., Nataro, J. P., & Mobley, H. L. T. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro818 · Cited by 5,583
Mutations of bacteria from virus sensitivity to virus resistance
Luria, S. E., & Delbrück, M. (1943) · Genetics · doi:10.1093/genetics/28.6.491 · Cited by 3,894
Trade-Offs in Life-History Evolution
Stearns, S. C. (1989) · Functional Ecology · doi:10.2307/2389364 · Cited by 2,852
A new antibiotic kills pathogens without detectable resistance
Ling, L. L., Schneider, T., Peoples, A. J., Spoering, A. L., Engels, I., Conlon, B. P., Mueller, A., Schäberle, T. F., Hughes, D. E., Epstein, S., et al. (2015) · Nature · doi:10.1038/nature14098 · Cited by 2,428
Bacteriophage resistance mechanisms
Labrie, S. J., Samson, J. E., & Moineau, S. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2315 · Cited by 2,397
Antibiotics and Bacterial Resistance in the 21st Century
Fair, R. J., & Tor, Y. (2014) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s14459 · Cited by 1,955
Spellberg, B., Guidos, R., Gilbert, D., Bradley, J., Boucher, H. W., Scheld, W. M., Bartlett, J. G., Edwards, J., & the Infectious Diseases Society of America (2008) · Clinical Infectious Diseases · doi:10.1086/524891 · Cited by 1,642
INDEPENDENT FUNCTIONS OF VIRAL PROTEIN AND NUCLEIC ACID IN GROWTH OF BACTERIOPHAGE
Hershey, A. D., & Chase, M. (1952) · Journal of General Physiology · doi:10.1085/jgp.36.1.39 · Cited by 1,601
General Nature of the Genetic Code for Proteins
CRICK, F. H. C., BARNETT, L., BRENNER, S., & WATTS-TOBIN, R. J. (1961) · Nature · doi:10.1038/1921227a0 · Cited by 1,390
Schooley, R. T., Biswas, B., Gill, J. J., Hernandez-Morales, A., Lancaster, J., Lessor, L., Barr, J. J., Reed, S. L., Rohwer, F., Benler, S., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00954-17 · Cited by 1,254
Cited by
The gut-liver axis in liver disease: Pathophysiological basis for therapy
Albillos, A., de Gottardi, A., & Rescigno, M. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.003 · Cited by 2,166
Phage therapy: From biological mechanisms to future directions
Strathdee, S. A., Hatfull, G. F., Mutalik, V. K., & Schooley, R. T. (2023) · Cell · doi:10.1016/j.cell.2022.11.017 · Cited by 817
The global preclinical antibacterial pipeline
Theuretzbacher, U., Outterson, K., Engel, A., & Karlén, A. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0288-0 · Cited by 738
The human virome: assembly, composition and host interactions
Liang, G., & Bushman, F. D. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00536-5 · Cited by 624
Phage Therapy for Antibiotic-Resistant Bacterial Infections
Hatfull, G. F., Dedrick, R. M., & Schooley, R. T. (2022) · Annual Review of Medicine · doi:10.1146/annurev-med-080219-122208 · Cited by 571
Host–microbiota interactions in immune-mediated diseases
Ruff, W. E., Greiling, T. M., & Kriegel, M. A. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0367-2 · Cited by 487
Resistance of Gram-Positive Bacteria to Current Antibacterial Agents and Overcoming Approaches
Jubeh, B., Breijyeh, Z., & Karaman, R. (2020) · Molecules · doi:10.3390/molecules25122888 · Cited by 383
Ma, J., Song, X., Li, M., Yu, Z., Cheng, W., Yu, Z., Zhang, W., Zhang, Y., Shen, A., Sun, H., et al. (2023) · Microbiological Research · doi:10.1016/j.micres.2022.127249 · Cited by 308
Systematic exploration of Escherichia coli phage–host interactions with the BASEL phage collection
Maffei, E., Shaidullina, A., Burkolter, M., Heyer, Y., Estermann, F., Druelle, V., Sauer, P., Willi, L., Michaelis, S., Hilbi, H., et al. (2021) · PLOS Biology · doi:10.1371/journal.pbio.3001424 · Cited by 305
Extracellular Vesicle Biogenesis and Functions in Gram-Positive Bacteria
Briaud, P., & Carroll, R. K. (2020) · Infection and Immunity · doi:10.1128/iai.00433-20 · Cited by 297
The gut virome: A new microbiome component in health and disease
Cao, Z., Sugimura, N., Burgermeister, E., Ebert, M. P., Zuo, T., & Lan, P. (2022) · eBioMedicine · doi:10.1016/j.ebiom.2022.104113 · Cited by 291
Eskenazi, A., Lood, C., Wubbolts, J., Hites, M., Balarjishvili, N., Leshkasheli, L., Askilashvili, L., Kvachadze, L., van Noort, V., Wagemans, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27656-z · Cited by 287
The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies
Liu, D., Van Belleghem, J. D., de Vries, C. R., Burgener, E., Chen, Q., Manasherob, R., Aronson, J. R., Amanatullah, D. F., Tamma, P. D., & Suh, G. A. (2021) · Viruses · doi:10.3390/v13071268 · Cited by 268
Antibiotic resistance: turning evolutionary principles into clinical reality
Andersson, D. I., Balaban, N. Q., Baquero, F., Courvalin, P., Glaser, P., Gophna, U., Kishony, R., Molin, S., & Tønjum, T. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa001 · Cited by 238
Escherichia coli Residency in the Gut of Healthy Human Adults
Martinson, J. N. V., & Walk, S. T. (2020) · EcoSal Plus · doi:10.1128/ecosalplus.esp-0003-2020 · Cited by 197
Bacteriophages and the Immune System
Popescu, M., Van Belleghem, J. D., Khosravi, A., & Bollyky, P. L. (2021) · Annual Review of Virology · doi:10.1146/annurev-virology-091919-074551 · Cited by 178
High-throughput mapping of the phage resistance landscape in E. coli
Mutalik, V. K., Adler, B. A., Rishi, H. S., Piya, D., Zhong, C., Koskella, B., Kutter, E. M., Calendar, R., Novichkov, P. S., Price, M. N., et al. (2020) · PLOS Biology · doi:10.1371/journal.pbio.3000877 · Cited by 171
“Moreover, identifying phages that select for resistance that have interrelated phenotypic consequences with, for example, antibiotic sensitivity is a recent advancement in the field that could directly benefit from these screening approaches [33,53,97,243].”
InfluentialGaborieau, B., Vaysset, H., Tesson, F., Charachon, I., Dib, N., Bernier, J., Dequidt, T., Georjon, H., Clermont, O., Hersen, P., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01832-5 · Cited by 141
Phages overcome bacterial immunity via diverse anti-defence proteins
(2023) · doi:10.1038/s41586-023-06869-w · Cited by 138
Capsules and their traits shape phage susceptibility and plasmid conjugation efficiency
Haudiquet, M., Le Bris, J., Nucci, A., Bonnin, R. A., Domingo-Calap, P., Rocha, E. P. C., & Rendueles, O. (2024) · Nature Communications · doi:10.1038/s41467-024-46147-5 · Cited by 72
The genetic basis of phage susceptibility, cross-resistance and host-range in Salmonella
Adler, B. A., Kazakov, A. E., Zhong, C., Liu, H., Kutter, E., Lui, L. M., Nielsen, T. N., Carion, H., Deutschbauer, A. M., Mutalik, V. K., et al. (2021) · Microbiology · doi:10.1099/mic.0.001126 · Cited by 65
Naik, G. A. R. R., Roy, A. A., Mutalik, S., & Dhas, N. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134977 · Cited by 47
Mobile integrons encode phage defense systems
Kieffer, N., Hipólito, A., Ortiz-Miravalles, L., Blanco, P., Delobelle, T., Vizuete, P., Ojeda, F. M., Jové, T., Jurenas, D., García-Quintanilla, M., et al. (2025) · Science · doi:10.1126/science.ads0915 · Cited by 40
Humolli, D., Piel, D., Maffei, E., Heyer, Y., Agustoni, E., Shaidullina, A., Willi, L., Imwinkelried, P., Estermann, F., Cuénod, A., et al. (2025) · PLOS Biology · doi:10.1371/journal.pbio.3003063 · Cited by 36
Mutalik, V. K., & Arkin, A. P. (2022) · iScience · doi:10.1016/j.isci.2022.104121 · Cited by 32
Gu, S., Shao, Z., Qu, Z., Zhu, S., Shao, Y., Zhang, D., Allen, R., He, R., Shao, J., Xiong, G., et al. (2025) · Science Advances · doi:10.1126/sciadv.adq5038 · Cited by 31
Kim, K., Jang, H., Kim, E., Kim, H., & Sung, G. Y. (2023) · Experimental Dermatology · doi:10.1111/exd.14940 · Cited by 24
Alessa, O., Aiba, Y., Arbaah, M., Hidaka, Y., Watanabe, S., Miyanaga, K., Wannigama, D. L., & Cui, L. (2025) · Molecules · doi:10.3390/molecules30153132 · Cited by 21
An enterococcal phage protein inhibits type IV restriction enzymes involved in antiphage defense
Bullen, N. P., Johnson, C. N., Andersen, S. E., Arya, G., Marotta, S. R., Lee, Y.-J., Weigele, P. R., Whitney, J. C., & Duerkop, B. A. (2024) · Nature Communications · doi:10.1038/s41467-024-51346-1 · Cited by 13
Cystic fibrosis – Ten promising therapeutic approaches in the current era of care
Somayaji, R., Nichols, D. P., & Bell, S. C. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1805733 · Cited by 12
Molecular mechanism of bacteriophage contraction structure of an S-layer–penetrating bacteriophage
Wilson, J. S., Fortier, L.-C., Fagan, R. P., & Bullough, P. A. (2025) · Life Science Alliance · doi:10.26508/lsa.202403088 · Cited by 9
(2023) · doi:10.1007/s00705-023-05817-3 · Cited by 3
Metadata
- Authors
- Kortright, K. E., Chan, B. K., Koff, J. L., & Turner, P. E.
- Venue
- Cell Host & Microbe
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 25
- Issue
- 2
- Pages
- 219-232
- ISSN
- 1931-3128 (ISSN-L)
- OpenAlex
- W2911362701
- Cited by
- 1,212
- References
- 85
- FWCI
- 65.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.